Protocol for ribosome-protected fragment isolation from rare leukemia cell populations

Christina Mayerhofer1, Ernst Mayerhofer2, Dan Li3

  • 1Center for Cancer Research and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Stem Cell Institute, Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

STAR Protocols
|September 27, 2026
PubMed